Based on the ki:e SB-C, a speech biomarker measuring cognition in a 10-15 minute test, Mild Cognitive Impairment (MCI) can be identified in a population of healthy controls or people with subjective complaints with an Area under the curve (AUC) of 0.81. The screening can be deployed via the Mili platform and integrated with other systems.
The 10-15 minute test has been shown to separate MCI from participants that are cognitively normal (healthy controls or subjective impairments) and patients with more severe impairments (dementia/major cognitive impairment). Sensitivity and specificity can be tuned to the use case by altering the cut-off.
A collection of evidence is available as a separate dossier.
StROC-AUC of 0.83 in separating people with subjective complaints and MCI.
PPV/1-NPV and consequences for different cut-offs in screening.
Using ki:e SB-C screening fro MCI will significantly reduce the number of candidates invited to sites for screening and improve successful screen-in rate.
We’re looking forward to working with you! SB-C screening for MCI is deployed via our Mili platform into clinical studies and trials. If you are interested in deploying it in your study, please reach out to us.
Academic groups wanting to use the technology can partner with us to receive reduced licensing costs.
Your message (optional)
I agree that my details from the contact form are collected and processed to answer my enquiry. The data will be stored for 10 years or deleted upon request.
Note: You can revoke your consent for the future at any time by sending an email to [email protected] Detailed information on the handling of user data can be found in our data protection statement.